Quality Assessment of Randomized Controlled Trials of Acupuncture for Chronic Obstructive Pulmonary Disease Based on the CONSORT Extended Statement and STRICTA Checklist

Objective To assess the methodology,reporting quality and intervention reporting quality of randomised controlled trials(RCT)of acupuncture for chronic obstructive pulmonary disease(COPD).Methods Randomized controlled trials of acupuncture for the treatment of chronic obstructive pulmonary disease from the establishment of the database to March 1,2023 through computer system search of CNKI,Wanfang,VIP,SinoMed,and PubMed databases.Two researchers independently conducted literature search,relevant data extraction,etc.,and assessed the quality of reports using the bias assessment tools ROB2,CONSORT Extended Statement and STRICTA List of Cochrane Systematic Review Manuals.Results After excluding non-compliant articles through the developed exclusion criteria,31 RCT remained.A methodological assessment of the included RCT according to the Cochrane website bias assessment tool ROB2 showed that 9 studies(29.03%)were at high risk of bias and no studies at low risk of bias.The CONSORT extended statement based on non-drug randomized controlled trials evaluated the quality of the literature,indicating that the reporting rate in terms of methods,results,trial protocol registration,etc.was low.The results of the evaluation according to the entries in the STRICTA list show that most of the literature does not describe the details of acupuncture and the background of the therapist in sufficient detail,but the reasonableness of acupuncture treatment is relatively complete.Conclusion At present,the quality of randomized controlled trials of acupuncture for COPD is generally low,and it is recommended that future researchers strictly follow the internationally recognized CONSORT statement and STRICTA list for trial protocol design and study result reporting.